The FIRCE-1 trial investigating the CAR T-cell therapy firi-cel in relapsed/refractory large B-cell lymphoma has been ...

Two months after Allogene abandoned plans for its CAR-T in leukemia, analysts have suggested that fresh phase 1 data in ...

The patient worked in an office and lived in an urban area of New England with his spouse and a cat; the cat had ... s disease and diffuse large B-cell lymphoma, can cause fever and hilar ...

A 60-year-old female patient presented with a rare case of coexisting diffuse large B-cell lymphoma (DLBCL) and classical Hodgkin lymphoma. This case report was published in Cureus, highlighting the ...

The various lymphomas are not the same as the lymphomas described previously by FDA as Breast Implant Associated Anaplastic Large Cell Lymphoma ... the capsule may be rare. The FDA recommends ...

A rare case of diffuse large B-cell lymphoma (DLBCL) accompanied by cold agglutinin disease (CAD) has been documented. This case report was published in the Journal of Medical Case Reports.

Intravascular large B-cell lymphoma (IVLBCL) is a rare and highly malignant non-Hodgkin B-cell lymphoma with uncommon clinical presentation and poor prognosis. The diagnostic pitfall of IVLBCL is ...

10,12 In patients with T-cell/histiocyte-rich large B-cell lymphoma, B symptoms and hepatosplenomegaly are commonly observed. Patients with anaplastic lymphoma kinase (ALK)-positive large B-cell ...

and this can lead to the discovery of rare and/or novel cell populations. This study provides an updated, comprehensive list of immunophenotyping markers for cats and dogs. A limitation of this study ...